Stock Markets

EnerCom Announces Chris Wright, Chairman and Chief Executive Officer of Liberty Energy, as Keynote Speaker at the 29th Annual EnerCom Denver – The Energy Investment Conference

Published

4 months ago

May 15, 2024

Register now for the 29^th annual EnerCom Denver “ The Energy Investment Conference featuring a diverse group of public and private energy companies at www.enercomdenver.com

A growing list of companies has confirmed their participation, and additional companies are being added to the lineup daily

Presentation opportunities are available for E&P, Midstream, OFS, and Energy Transition companies

DENVER, May 14, 2024 /PRNewswire/ — EnerCom, Inc. is pleased to announce that Chris Wright, Chairman, and Chief Executive Officer of Liberty Energy, will be the lunch keynote speaker on Monday, August 19, 2024, at EnerCom Denver – The Energy Investment Conference. For the past 29 years, EnerCom Denver has been the largest independent investor conference for the global oil and gas industry and broadening energy industry that is open to all energy companies, investors, and professionals to participate. This year’s conference will occur August 18-21, 2024, at The Westin Denver Downtown.

Institutional investors, portfolio managers, financial analysts, CIOs, and other investment community and industry professionals are encouraged to register now for EnerCom Denver at www.EnerComDenver.com. The conference is free for qualified investment professionals.

About Chris Wright

Chris Wright is the Founder and Chief Executive Officer of Liberty Energy. He is a self-described tech nerd turned entrepreneur and a dedicated humanitarian on a mission to better human lives. This passion has inspired a career in energy working not only in oil and gas, but fusion, solar, and geothermal. Chris completed an undergraduate degree in Mechanical Engineering at MIT and graduate work in Electrical Engineering at both UC Berkeley and MIT. On top of his role with Liberty Energy, he serves on the board of numerous organizations and nonprofits. Chris grew up and currently lives in Colorado with his wife, Liz. He is a passionate father, skier, cyclist, climber, and outdoor enthusiast.

Presenting company lineup as of May 14, 2024, includes:

Africa Oil (OTC:) (TSX: AOI)
Amplify Energy (NYSE: NYSE:)
APA Corporation (NASDAQ: APA)
Aureus Energy Services
Avant Natural Resouces
Bayswater
Baytex Energy (TSX/ NYSE: NYSE:)
Berry Corporation (NASDAQ: BRY)
Bison Oil & Gas
Calfrac Well Services (TSX: CFW)
Chapman Nuclear
Chevron (NYSE: NYSE:)
Civitas Resources (NYSE: CIVI)
Diversified Energy (NYSE: DEC)
DNOW (NYSE: DNOW)
Donovan Ventures
EnerCom Inc.
Flotek Industries (NYSE: FTK)
Forum Energy Technologies (NYSE: FET)
Franklin Mountain Energy
Gradient Geothermal
Granite Ridge Resources (NYSE: GRNT)
Hemisphere Energy (TSX: HME)
Kelt Exploration (TSX: KEL)
Liberty Energy (NYSE: LBRT)
LiTHOS (OTC: LITSF)
Lycos Energy (TSXV: LCX)
Mobius Risk Group (TSXV: LCX)
NCS Multistage (NASDAQ: NCSM)
NuVista Energy (TSX: NVA)
Paradigm by Puloli
Parex Resources (OTC: PARXF)
Pason Systems (TSX: PSI)
PetroTal Corp. (TSXV: TAL)
Pine Cliff Energy (TSX: PNE)
Pulse Seismic (TSX: PSD)
ReconAfrica (OTC: RECAF)
(NYSE: REI)
SandRidge Energy (NYSE: SD)
SilverBow Resources (NYSE: NYSE:)
SM Energy (NYSE: NYSE:)
Standard Energy Partners
Tenaz Energy (TSX: TNZ)
Trellis Energy Partners
VAALCO Energy (NYSE: EGY)
Vitesse Energy (NYSE: VTS)
W&T Offshore (NYSE: NYSE:)
Walker Lane Research Partners
Wasatch Energy Management
Zephyr Energy plc (AIM: ZPHR; OTCQB: ZPHRF)

The complete schedule of presenters and events can be found on the conference website (presenters, days, and times are subject to change). New presenters continue to be added to the schedule.

Conference Details: EnerCom Denver – The Energy Investment Conference offers investment professionals a unique opportunity to network and listen to senior management teams from leading companies across the energy value chain update investors on their operational and financial strategies and learn how they are creating value for stakeholders.

Conference Dates: August 18 – 21, 2024. EnerCom will host its annual Charity Golf Tournament on Sunday, August 18^th at the scenic Arrowhead Golf Club in Littleton, Colorado. The EnerCom Denver Golf Tournament — a fundraiser for IN! Pathways to Inclusive Higher Education — requires a $150 donation to participate. The tournament is sponsored by the conference Global Sponsor Netherland, Sewell & Associates, Inc. (NSAI).

Formal presentations and meetings will be held Monday, August 19^th through Wednesday, August 21^st.

Venue: Westin Denver Downtown. We highly encourage attendees to book hotel rooms under the EnerCom group block, as space is limited.

Who Attends the Conference: Institutional, private equity, hedge fund investors, family offices, research analysts, retail brokers, trust officers, high net worth investors, investment and commercial bankers, and energy industry professionals gather in Denver throughout the conference.

Qualified investment professionals and oil and gas company executives may register for the event at no cost through the conference website. Other conference registration classifications are available for a fee.

Conference Format and Details: The EnerCom Denver conference follows EnerCom’s familiar 25-minute presentation format, followed by 50-minute Q&A opportunities in separate breakout rooms, one-on-one meetings, and multiple networking opportunities. In addition to in-person access to all company presentations, panel discussions, and keynote speakers, conference registration allows investors and management teams to meet formally and informally over cocktails, breakfast, and lunch.

Presenter Inquiries: Companies interested in presenting at EnerCom Denver can contact Larry Busnardo at lbusnardo@enercominc.com.

Investor One-on-One Meetings: Qualified investors can request one-on-one meetings with company management teams through the conference website. EnerCom will announce when one-on-one meeting requests for investor scheduling are available. Meetings are limited to institutional investors, buy-side principals, portfolio managers, CIOs, and securities analysts. EnerCom can work in advance with presenting company management teams to arrange one-on-one meetings with the attending institutional investors and research analysts at the conference venue. Please contact Larry Busnardo at lbusnardo@enercominc.com with questions regarding one-on-one meetings.

Sponsorship Opportunities: Please contact Blanca Andrus at bandrus@enercominc.com or (303) 296.8834 x246.

About EnerCom, Inc.:

Founded in 1994, EnerCom, Inc. has been a trusted advisor to the global energy industry, working with clients to differentiate and deliver targeted messages to investors. Headquartered in Denver, EnerCom is an internationallyrecognized strategic communications and management consultancy that advises companies on, investor relations, corporate strategy/board advisory, Environmental, Social & Governance (ESG), marketing, financial analysis and valuation, media, branding, and visual communications design.

For more information about EnerCom and its services, please visit www.enercominc.com or call +1 303-296-8834 to speak with the management team or one of our consultants.

EnerCom Denver Sponsors Include:

Netherland, Sewell & Associates, Inc. (NSAI)

Netherland, Sewell & Associates, Inc. (NSAI) was founded in 1961 to provide the highest quality engineering and geological consulting to the petroleum industry. Today they are recognized as the worldwide leader of petroleum property analysis to industry and financial organizations and government agencies. With offices in Dallas and Houston, NSAI provides a complete range of geological, geophysical, petrophysical, and engineering services and has the technical experience and ability to perform these services in any of the onshore and offshore oil and gas producing areas of the world. They provide reserves reports and audits, acquisition and divestiture evaluations, simulation studies, exploration resources assessments, equity determinations, and management and advisory services. netherlandsewell.com

Mobius Risk Group

Mobius Risk Group is an independent commodity and physical energy risk advisory firm. Founded in 2002, Mobius provides strategic advisory services including financial, physical, and commodity risk management and valuation, carbon strategy development, and regulated energy oversight for producers, consumers, distributors and capital providers backed by its proprietary C/ETRM, RiskNet. mobiusriskgroup.com

Haynes and Boone, LLP

Haynes Boone is an energy-focused corporate law firm that provides a full spectrum of legal services and solutions to clients across the energy industry, including the upstream, midstream and downstream sectors as well as power and renewables. Our team of more than 100 energy lawyers and landmen has been helping operators, lenders, and private equity firms with some of their most complex and significant transactions and disputes in recent years. The firm’s nearly 700 lawyers practice across 19 global offices located in California, Colorado, Illinois, New York, North Carolina, Texas, Virginia, Washington, D.C., London, Mexico City and Shanghai. The 2023 Chambers USA Legal Guide ranked 31 different firm practice areas, and in 2024, Haynes Boone became the first Am Law 100 firm to ever earn a Gold-level Bell Seal from Mental Health America. The U.S. News & World Report and Best Lawyers “Best Law Firms” 2023 survey ranked Haynes Boone in National Tier 1 in Oil & Gas Law. haynesboone.com

IMA

IMA Financial Group is an independent broker defining the future of insurance through comprehensive and consultative risk and wealth management services. A majority employee-owned and managed company, its 2,300-plus associates’ in offices across the country are empowered by a shared mission to manage risk, protect assets, and make a difference. IMA Corp.

Stock Markets

Five9 stock hits 52-week low at $28.74 amid market challenges

Published

21 hours ago

September 7, 2024

In a turbulent market environment, Five9 (NASDAQ:) Inc’s stock has touched a 52-week low, reaching a price level of $28.74. This significant downturn reflects a broader trend for the cloud software company, which has seen its shares plummet by -58.79% over the past year. Investors are closely monitoring Five9’s performance as it navigates through a period of heightened volatility and shifting industry dynamics, which have contributed to the stock’s current valuation at this low point. The company’s efforts to rebound from this position will be under scrutiny in the coming quarters as market participants look for signs of a strategic turnaround or further indications of market pressures.

In other recent news, Five9 Inc . has achieved an annual revenue run rate exceeding $1 billion in Q2, a significant milestone despite lowering its annual revenue guidance by 3.8% due to customer budget constraints. The company’s adjusted EBITDA margin rose to 17% of revenue, contributing to a strong operating cash flow of $126 million. The company also confirmed plans to reduce its global workforce by approximately 7% by the end of 2024, a strategic move projected to cost between $12 million and $15 million.

Five9’s recent acquisition of Acqueon, a firm specializing in proactive outbound omnichannel customer engagement, aims to expand its AI offerings and bolster its growth. This move is in line with the company’s focus on managing expenses and improving profitability, with initiatives like FedRAMP and expansion into India anticipated to improve gross margins.

In their analysis, Piper Sandler maintained an Overweight rating for Five9, with a steady price target of $47.00, while Needham and BTIG both maintained a Buy rating with price targets of $48.00 and $45.00 respectively. These ratings reflect the firms’ confidence in Five9’s strategic positioning and potential for growth, despite the current challenges and workforce reduction.

InvestingPro Insights

Amid the current market conditions, Five9 Inc’s recent performance can be put into perspective with select data from InvestingPro. The company’s market capitalization stands at roughly $2.15 billion, indicating the size and scale of the business amidst its challenges. Despite the stock’s decline, analysts are showing a hint of optimism, with 20 analysts having revised their earnings estimates upwards for the upcoming period. This could signal a potential turnaround in sentiment or underlying business performance.

Importantly, Five9’s liquid assets are reported to surpass short-term obligations, suggesting that the company maintains a degree of financial flexibility to navigate its current difficulties. Furthermore, while the stock is trading near its 52-week low, it’s worth noting that the relative strength index (RSI) suggests the stock is in oversold territory, which can sometimes precede a rebound in share price. Investors looking for comprehensive analysis and additional InvestingPro Tips on Five9 can find more insights, including 14 other tips, at https://www.investing.com/pro/FIVN.

In terms of financial health, the company operates with a moderate level of debt and is expected to become profitable this year, according to analysts’ predictions. These elements may offer some solace to investors considering the stock’s substantial price fall over the last year. For those seeking a deeper dive into Five9’s valuation and future prospects, the InvestingPro platform provides a fair value estimate of $45.04, which is considerably higher than the current trading price, suggesting potential undervaluation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Stock Markets

TD Cowen maintains Buy on Terns Pharmaceuticals

Published

21 hours ago

September 7, 2024

TD Cowen reiterated its Buy rating on shares of Terns Pharmaceuticals (NASDAQ:TERN), following the company’s investor call. The call was held to manage expectations for the upcoming Phase 1/2 CARDINAL study data for chronic myeloid leukemia (CML). The firm noted the challenges in measuring the efficacy endpoint (EP) due to disease progression and the absence of treatment switch guidelines, which makes major molecular response (MMR) a challenging efficacy endpoint for Phase 1/2 trials.

The interim Phase 1/2 data aims to evaluate descriptive efficacy signals, considering patients’ baseline BCR-ABL levels and treatment history. The analyst highlighted that the once-daily (QD) dosing and the lack of food effect could potentially enhance the quality of life for patients compared to other allosteric tyrosine kinase inhibitors (TKIs).

Terns Pharmaceuticals has been focusing on the development of improved treatment options for CML. The company’s approach to dosing, which does not require food intake, may offer a more convenient alternative for patients, potentially leading to better adherence and outcomes.

The topline data from the 6-month Phase 1/2 CARDINAL study is anticipated to be available in 2025. This data will provide further insights into the treatment’s efficacy and safety, which are critical factors in the ongoing development and potential approval process.

Investors and stakeholders in Terns Pharmaceuticals are expected to closely monitor the progress of the CARDINAL study, as it could have a significant impact on the company’s future prospects and position in the CML treatment landscape.

In other recent news, Terns Pharmaceuticals has experienced significant developments. The biopharmaceutical company reported robust earnings and revenue results, with Mizuho Securities maintaining an Outperform rating on Terns shares, citing strong enthusiasm for the company’s drug, TERN-701, a potential treatment for chronic myeloid leukemia.

The firm expects the first interim Phase 1 CARDINAL study data for TERN-701 in December.

Terns also announced the appointment of Elona Kogan as its new chief legal officer, a move that underscores the company’s strategic development and pipeline advancement.

The company also secured an extension of its office lease in Foster City, California, through 2027, reflecting Terns Pharmaceuticals’ operational stability and long-term planning.

In terms of clinical trials, Terns has made progress in its ongoing Phase 1 study of TERN-701, with interim findings suggesting the drug can be administered once daily with or without food.

This development, coupled with the forthcoming Phase 1 data for another of Terns’ drugs, TERN-601—an oral GLP-1 receptor agonist for obesity—expected next month, underscores the company’s commitment to innovative therapies.

These recent developments, from financial performance to executive appointments and clinical trials, highlight Terns Pharmaceuticals’ ongoing efforts to advance its strategic objectives and deliver on its mission. The company’s activities are closely watched by investors and industry analysts, including those from Mizuho Securities, who continue to support the company’s potential.

InvestingPro Insights

As Terns Pharmaceuticals (NASDAQ:TERN) navigates the complexities of its Phase 1/2 CARDINAL study, investors are keeping a keen eye on the company’s financial health and stock performance. According to InvestingPro, Terns holds more cash than debt, which is a positive signal for financial stability. Additionally, with five analysts revising their earnings upwards for the upcoming period, there is a sense of optimism about the company’s potential performance.

However, it’s important to note that Terns is not currently profitable and has been quickly burning through cash, which may raise concerns about long-term sustainability. The company’s P/E Ratio stands at -5.71, reflecting these profitability challenges. Despite these hurdles, Terns has managed a 1 Year Price Total Return of 45.42%, indicating some investor confidence in the company’s growth prospects. The anticipated fair value from analysts stands at 15 USD, while the InvestingPro Fair Value is calculated at 5.8 USD, highlighting a divergence in valuation perspectives.

For those looking for more in-depth analysis, additional InvestingPro Tips on Terns Pharmaceuticals can be found at https://www.investing.com/pro/TERN, offering a comprehensive look at the company’s financial details and stock performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Stock Markets

Macron discussed support for Ukraine and Gaza ceasefire with Germany’s Scholz

Published

21 hours ago

September 7, 2024

© Reuters. France's President Emmanuel Macron and Germany's Chancellor Olaf Scholz shake hands as they meet during the 33rd Evian Annual Meeting to promote economic co-operation at Evian in the French Alps, France, September 6, 2024. Olivier Chassignole/Pool via REUTERS

PARIS (Reuters) – French President Emmanuel Macron discussed the importance of maintaining support for Ukraine and the need for a ceasefire in Gaza during talks on Friday with German Chancellor Olaf Scholz, said the French presidency.

Regarding Ukraine, the two leaders expressed their determination to support the country “for as long and as intensively as necessary” in its war against Russia, the Elysee said.